To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Health: Children
Monday 29th April 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of her policies on health outcomes for children who live in poverty.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.

The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.

The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.

In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:

https://fingertips.phe.org.uk/profile/child-health-profiles


Written Question
Driving Licences: Medical Examinations
Monday 29th April 2024

Asked by: Beth Winter (Labour - Cynon Valley)

Question to the Department for Transport:

To ask the Secretary of State for Transport, how many medical professionals' assessments of fitness to drive have been received by the DVLA in each month of the last five years.

Answered by Guy Opperman - Parliamentary Under-Secretary (Department for Transport)

The Driver and Vehicle Licensing Agency (DVLA) is currently engaging with the Professional Fees Committee of the British Medical Association in respect of the fees paid for medical information required for driver licensing purposes.

The DVLA is also reviewing the questionnaires issued to medical professionals when medical information is required to assist in assessing an individual’s fitness to drive; with a view to simplifying the process wherever possible.

The DVLA has introduced a simplified licence renewal process for drivers with epilepsy, multiple sclerosis, some mental health conditions, and glaucoma. This renewal process has significantly reduced the need for the DVLA to seek further information from medical professionals and enabled more licensing decisions to be made based on the information provided by the driver. The DVLA is considering adding more medical conditions to this process.

In July 2022, the law changed to widen the pool of registered healthcare professionals who can provide information as part of the DVLA’s medical investigations into a person’s fitness to drive. Previously, this could only be provided by a doctor. This provides GP surgeries and hospital teams greater flexibility to decide how they manage the DVLA’s requests for information.

These changes will all help to simplify or reduce the number of times the DVLA needs to seek further information from medical professionals.

The length of time taken to process a driving licence application where a medical condition needs to be investigated depends on the condition(s) involved and if further medical information, tests, or examinations are required.

The DVLA, acting on behalf of the Secretary of State for Transport, is required to ensure that all drivers meet the medical standards for driving before a licence is issued. These investigations can often involve seeking further information about an individual’s medical condition(s) from the relevant healthcare professionals. However, it is important to note that the DVLA does not ask medical professionals to assess an individual’s fitness to drive, and as such, figures about how many such assessments have been received from medical professionals are not available.


Written Question
Driving Licences: Medical Examinations
Monday 29th April 2024

Asked by: Beth Winter (Labour - Cynon Valley)

Question to the Department for Transport:

To ask the Secretary of State for Transport, how many medical professionals' assessments of fitness to drive have been received by the DVLA in each year since 2004.

Answered by Guy Opperman - Parliamentary Under-Secretary (Department for Transport)

The Driver and Vehicle Licensing Agency (DVLA) is currently engaging with the Professional Fees Committee of the British Medical Association in respect of the fees paid for medical information required for driver licensing purposes.

The DVLA is also reviewing the questionnaires issued to medical professionals when medical information is required to assist in assessing an individual’s fitness to drive; with a view to simplifying the process wherever possible.

The DVLA has introduced a simplified licence renewal process for drivers with epilepsy, multiple sclerosis, some mental health conditions, and glaucoma. This renewal process has significantly reduced the need for the DVLA to seek further information from medical professionals and enabled more licensing decisions to be made based on the information provided by the driver. The DVLA is considering adding more medical conditions to this process.

In July 2022, the law changed to widen the pool of registered healthcare professionals who can provide information as part of the DVLA’s medical investigations into a person’s fitness to drive. Previously, this could only be provided by a doctor. This provides GP surgeries and hospital teams greater flexibility to decide how they manage the DVLA’s requests for information.

These changes will all help to simplify or reduce the number of times the DVLA needs to seek further information from medical professionals.

The length of time taken to process a driving licence application where a medical condition needs to be investigated depends on the condition(s) involved and if further medical information, tests, or examinations are required.

The DVLA, acting on behalf of the Secretary of State for Transport, is required to ensure that all drivers meet the medical standards for driving before a licence is issued. These investigations can often involve seeking further information about an individual’s medical condition(s) from the relevant healthcare professionals. However, it is important to note that the DVLA does not ask medical professionals to assess an individual’s fitness to drive, and as such, figures about how many such assessments have been received from medical professionals are not available.


Select Committee
Leonard Cheshire
DYE0055 - Disability employment

Written Evidence Apr. 26 2024

Inquiry: Disability employment
Inquiry Status: Closed
Committee: Work and Pensions Committee (Department: Department for Work and Pensions)

Found: for all disabled people currently stands at 54.2% but can fall below 33% for disabled people with epilepsy


Select Committee
The Salvation Army
DYE0041 - Disability employment

Written Evidence Apr. 26 2024

Inquiry: Disability employment
Inquiry Status: Closed
Committee: Work and Pensions Committee (Department: Department for Work and Pensions)

Found: stuff to deal with; I have a curved spine; my legs aren’t as strong as they used to be, and I have epilepsy


Select Committee
Child Poverty Action Group
DYE0031 - Disability employment

Written Evidence Apr. 26 2024

Inquiry: Disability employment
Inquiry Status: Closed
Committee: Work and Pensions Committee (Department: Department for Work and Pensions)

Found: year-old care leaver, known to adult social care and diagnosed with developmental disorders, epilepsy


Scottish Parliament Debate - Main Chamber
First Minister’s Question Time - Thu 25 Apr 2024

Mentions:
1: Stewart, Kevin (SNP - Aberdeen Central) research has revealed that in the UK there are shortages of life-saving medicines such as antibiotics, epilepsy - Speech Link


Written Question
Neuromuscular Disorders: Health Services
Wednesday 24th April 2024

Asked by: Dean Russell (Conservative - Watford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what support exists for those with (a) Huntington’s disease and (b) other complex neurological conditions.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Integrated care boards (ICBs) are responsible for commissioning most services for people with neurological conditions, including those with Huntington’s disease. At a national level, NHS England commissions the specialised elements of neurological care that patients may receive from 27 specialised neurological treatment centres across England. NHS England’s RightCare toolkit and Getting It Right First Time programme aim to improve care for people with neurological conditions, by reducing variation and delivering care more equitably across England.

New optimal clinical pathways for a range of neurological conditions were developed by the National Neurosciences Advisory Group, which ceased operation in 2022. These pathways set out what good treatment, care, and support should look like across a range of neurological conditions. They also help to guide and facilitate the commissioning of high-quality, effective neurology services by ICBs. The optimal clinical pathway for movement disorders outlines the care pathway that patients with Huntington’s disease should receive. Further information on the optimal clinical pathways are available at the following link:

https://www.nnag.org.uk/optimum-clinical-pathways

The Department funds research on neurological conditions through the National Institute for Health and Care Research (NIHR), and between 2018/19 and 2022/23, the Department spent £272.1 million on research into neurological conditions. This covers research into conditions such as Huntington’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. In 2022/23, the most recent year for which we have data, the Department, via the NIHR, spent £65.3 million on research into neurological conditions.


Early Day Motion
Gleniffer Thistle fundraising for Epilepsy Scotland (7 Signatures)
22 Apr 2024
Tabled by: Gavin Newlands (Scottish National Party - Paisley and Renfrewshire North)
That this House congratulates Gleniffer Thistle 2012 football team for their commitment and hard work in raising £725 for Epilepsy Scotland recently through a fundraising walk from Hampden Park to St. Mirren Park via two of Glasgow’s other football stadiums; notes that £1,475 was raised in total by the team, …
Written Question
Epilepsy: Greater London
Monday 22nd April 2024

Asked by: Helen Hayes (Labour - Dulwich and West Norwood)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the level of stocks of epilepsy medication in south London pharmacies as of 12 April 2024.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department has a role to play in ensuring that supplies of medicines are available nationally, and in sufficient quantity to meet demand. The Department does not monitor stocks of medicine at a local level, and as such no assessment has been made of the level of stocks of epilepsy medication in South London pharmacies.

The Department has been working intensively with the pharmaceutical industry, National Health Service, and others to address issues with the supply of some epilepsy medications. As a result of our action, some supply issues with Tegretol prolonged-release tablets have been resolved. However, some issues remain, and we are working with suppliers to resolve these as soon as possible by expediting future deliveries, and ensuring that alternative products remain available. We have issued guidance to healthcare professionals on how to manage patients requiring affected medicines while supply is disrupted. The Department has been engaging with the Epilepsy Society to keep them updated on developments.